Cargando…

Insights from the AQUA Registry: a retrospective study of anticholinergic polypharmacy in the United States

BACKGROUND: Anticholinergic (ACH) burden is a risk factor for negative health outcomes among older adults. Several medications contribute to ACH burden, including antimuscarinics used to manage overactive bladder (OAB). OBJECTIVES: This study aimed to understand the extent of ACH burden in an OAB po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooperberg, Matthew R., Mbassa, Rachel, Walker, David, Meeks, William, Lockefeer, Amy, Jiang, Baoguo, Li, Tina, Johnston, Karissa, Fang, Raymond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871979/ https://www.ncbi.nlm.nih.gov/pubmed/36703880 http://dx.doi.org/10.1177/17562872221150572

Ejemplares similares

A 12-Year Retrospective Study of the Prevalence of Anticholinergic Polypharmacy and Associated Outcomes Among Medicare Patients with Overactive Bladder in the USA
por: Campbell, Noll L., et al.
Publicado: (2021)

The evaluation of relationship between polypharmacy and anticholinergic burden scales
por: Okudur, Saadet Koc, et al.
Publicado: (2021)

Polypharmacy and cumulative anticholinergic burden in older adults hospitalized with fall
por: Wong, Ho Lun, et al.
Publicado: (2023)

Automated Detection of Patients at High Risk of Polypharmacy including Anticholinergic and Sedative Medications
por: Shirazibeheshti, Amirali, et al.
Publicado: (2023)

Mirabegron and antimuscarinic use in frail overactive bladder patients in the United States Medicare population
por: Johnson, Theodore M., et al.
Publicado: (2022)

Delirium is not associated with anticholinergic burden or polypharmacy in older patients on admission to an acute hospital: an observational case control study
por: Moorey, Hannah C., et al.
Publicado: (2016)

Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities
por: Ailabouni, Nagham, et al.
Publicado: (2017)

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models
por: Al Rihani, Sweilem B., et al.
Publicado: (2021)

Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial
por: van der Meer, Helene G, et al.
Publicado: (2018)

Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions
por: Rutman, Matthew P., et al.
Publicado: (2021)

Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study
por: Sumbul-Sekerci, Betul, et al.
Publicado: (2023)

Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial
por: Jamieson, Hamish, et al.
Publicado: (2023)

Anticholinergic burden measures, symptoms, and fall-associated risk in older adults with polypharmacy: Development and validation of a prognostic model
por: Dinh, Truc Sophia, et al.
Publicado: (2023)

Evaluation of the Effect of a Safe Medication Strategy on Potentially Inappropriate Medications, Polypharmacy and Anticholinergic Burden for People with Dementia: An Intervention Study
por: Kable, Ashley, et al.
Publicado: (2023)

Anticholinergic and antioxidant activities of usnic acid-an activity-structure insight
por: Cetin Cakmak, Kader, et al.
Publicado: (2019)

Are Anticholinergic Symptoms a Risk Factor for Falls in Older General Practice Patients With Polypharmacy? Study Protocol for the Development and Validation of a Prognostic Model
por: Dinh, Truc Sophia, et al.
Publicado: (2021)

Evaluating and understanding combination therapy decision drivers for the treatment of overactive bladder in the United States
por: Kraus, Stephen R., et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Urological Care Delivery in the United States
por: Lee, Daniel J., et al.
Publicado: (2021)

Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients
por: Gorup, Eva, et al.
Publicado: (2018)

Qualitative insights into general practitioners views on polypharmacy
por: Anthierens, Sibyl, et al.
Publicado: (2010)

The development of anticholinergics in the management of COPD
por: Scullion, Jane E
Publicado: (2007)

Anticholinergic Drugs in Nonallergic Rhinitis
por: Naclerio, Robert
Publicado: (2009)

The mode of action of anticholinergics in asthma
por: Gosens, Reinoud, et al.
Publicado: (2018)

Anticholinergic Drugs in Geriatric Psychopharmacology
por: López-Álvarez, Jorge, et al.
Publicado: (2019)

Anticholinergic Toxicity in the Emergency Department
por: McCoy, C Eric, et al.
Publicado: (2023)

A dataset quantifying polypharmacy in the United States
por: Quinn, Katie J., et al.
Publicado: (2017)

Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan
por: Al-Azayzih, Ahmad, et al.
Publicado: (2023)

Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Bergler, Ulrich, et al.
Publicado: (2021)

Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study
por: Krüger, Caroline, et al.
Publicado: (2021)

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
por: Salahudeen, Mohammed Saji, et al.
Publicado: (2015)

Safety and tolerability of inhalational anticholinergics in COPD
por: Sharafkhaneh, Amir, et al.
Publicado: (2013)

Anticholinergic Burden of Geriatric Ward Inpatients
por: Wilczyński, Krzysztof, et al.
Publicado: (2021)

Urinary reabsorption in the rat kidney by anticholinergics
por: Oe, Hideki, et al.
Publicado: (2021)

The anticholinergic burden: from research to practice
por: Hilmer, Sarah N, et al.
Publicado: (2022)

Anticholinergic syndrome in a patient with schizophrenia
por: Marco Estrada, O., et al.
Publicado: (2022)

The past, present and future of anticholinergic drugs
por: Healy, David
Publicado: (2023)

Serum Anticholinergic Activity: A Possible Peripheral Marker of the Anticholinergic Burden in the Central Nervous System in Alzheimer's Disease
por: Hori, Koji, et al.
Publicado: (2014)

Dose response relationship of cumulative anticholinergic exposure with incident dementia: validation study of Korean anticholinergic burden scale
por: Suh, Yewon, et al.
Publicado: (2020)

Mini Review: Anticholinergic Activity as a Behavioral Pathology of Lewy Body Disease and Proposal of the Concept of “Anticholinergic Spectrum Disorders”
por: Hori, Koji, et al.
Publicado: (2016)

Rising CNS Polypharmacy Among Older Adults in the United States
por: Maust, Donovan
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r1s73kck2iu98v67c2cda7fq2n